Lv1
20 积分 2020-09-29 加入
Post hoc comparison of the effectiveness of tocilizumab, rituximab, mycophenolate mofetil, and cyclophosphamide in patients with SSc-ILD from the EUSTAR database
2个月前
已完结
Chinese expert consensus on the diagnosis and treatment of IgG 4 related diseases
4个月前
已完结
[Recommendations for the diagnosis and treatment of IgG4-related disease in China]
4个月前
已完结
皖公网安备34019202002308
